India reports 2151 new COVID-19 cases in last 24 hours, daily postive rate of 1. 51 percent
Mar 29, 2023
New Delhi [India], March 29 : A total of new 2151 Covid cases were recorded in the last 24 hours across the country with a daily positive rate of 1.51 per cent, an official statement said on Wednesday, adding that 11,336 doses of vaccines were administered in the last 24 hours.
According to the release, 1,42,497 tests were conducted in the last 24 hours, taking the total number of tests conducted so far to 92.13 crores.
It stated further that a total of 1,222 recoveries were made from the virus in the last 24 hours, taking the total number of recoveries to 4,41,66,925.
It stated that 120.65 cr total vaccine doses (95.20 cr Second Dose and 22.86 cr Precaution Dose) have been administered so far under Nationwide Vaccination Drive.
Further, India's active caseload currently stands at 11,903 with a rate of 0.03 per cent per day and with a recovery rate currently standing at 98.78%.
It stated that the weekly positivity rate stands at 1.53%.
The Ministry of Health and Family Welfare has issued revised guidelines for Covid-19 in the wake of the surge of cases in the past week across the country.
"Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease," revised guidelines said.
As per the revised Covid-19 guidelines, maintain "Physical distancing, indoor mask use, hand hygiene, Symptomatic management (hydration, antipyretics, antitussive) Monitor temperature and oxygen saturation (by applying a SpO probe to fingers) Stay in contact with the treating physician.
"Seek immediate medical attention if difficulty breathing, High-grade fever/ severe cough, particularly if lasting for more than 5 days. A low threshold is to be kept for those with any of the high-risk features," guidelines discussed and prepared in January said.
Additionally, in moderate or severe diseases at high risk of progression, the guidelines recommend, "Consider Remdesivir for up to 5 days (200 mg IV on day 1 followed by 100 mg IV OD for the next 4 days)".
